First patient in HER2-positive breast cancer clinical trial defies odds and inspires hope in others
July 23, 2026
July 23, 2026
BIRMINGHAM, Alabama, July 23 -- The University of Alabama issued the following news:
* * *
First patient in HER2-positive breast cancer clinical trial defies odds and inspires hope in others
*
Rebecca Hall was diagnosed with leptomeningeal metastasis and was weeks from passing, until she enrolled as the first patient in a clinical trial. In 2019, Rebecca Hall, a Dothan, Ala., native who has lived in Birmingham since 2006, was told she had only . . .
* * *
First patient in HER2-positive breast cancer clinical trial defies odds and inspires hope in others
*
Rebecca Hall was diagnosed with leptomeningeal metastasis and was weeks from passing, until she enrolled as the first patient in a clinical trial. In 2019, Rebecca Hall, a Dothan, Ala., native who has lived in Birmingham since 2006, was told she had only . . .